NIH Announces More Long COVID Studies

PharmaNewsIntelligence (5/10, Salib) reported, “On Wednesday, May 8, 2024, the NIH announced plans to launch additional clinical trials as part of its Researching COVID to Enhance Recovery (RECOVER) Initiative to understand and address sleep disturbances, exercise intolerance, and post-exertional malaise in long COVID patients.” The studies “join six existing clinical trials in the RECOVER initiative focusing on viral persistence and neurological symptoms.” The agency “plans to enroll approximately 1,660 participants across 50 clinical trial sites.”